Hyperbaric Oxygen Treatment after Surgery and Radiation for Oral Cancers Does not Increase the Likelihood of a Second Primary Development, nor Reduce Disease Specific or Overall Survival

What Researchers Did

Researchers analyzed data from 6,297 patients in Taiwan who received HBOT after oral cancer surgery and radiation therapy to determine whether HBOT increased the risk of developing a second primary cancer.

What They Found

HBOT was not associated with an increased risk of second primary cancers in this large cohort. The findings aligned with existing evidence that HBOT does not promote tumor growth or new malignancies.

What This Means for Canadian Patients

A common concern among oncology patients considering HBOT is whether oxygen therapy might stimulate cancer recurrence or new tumor development. This large study provides reassuring evidence that HBOT is safe in this regard.

Canadian Relevance

No direct Canadian connection identified.

Study Limitations

Retrospective population data may not fully account for all confounding variables affecting cancer risk.